Antineoplastic activity and toxicity of some alkylating cytostatics (Cyclophosphamide, CCNU, Cytostasan) encapsulated in liposomes in different murine tumour models

References

• Anger G., Hesse P., Köhler P., Baufeld H. Klinischer Erfahrungsbericht über die Anwendung des neuen Zytostatikums 3393. Zeitschrift für die gesamte innere Medizin 1968; 23: 242–247
   PubMedGoogle Scholar
• Arndt D., Fichtner I. Liposomen-Darstellung, Eigenschaften, Anwendung. Akademie-Verlag, Berlin 1986
   Google Scholar
• Arndt D., Fichtner I., Reszka R., Elbe B. Darstellung, Eigenschaften und therapeutische Wirksamkeit von daunorubicinhaltigen Liposomen. Pharmazie 1983; 38: 331–335
   PubMedGoogle Scholar
• Arnold W., Nowak C. Metastatic screening models. Antitumor Drug Therapy Reports 1976; 2: 69–70
   Google Scholar
• Babbage J. W., Berenbaum M. C. Increased therapeutic efficiency of a lipidsoluble alkylating agent incorporated in liposomes. British Journal of Cancer 1982; 45: 830–834
   PubMedGoogle Scholar
• Liposome Letters, A. D. Bangham. Academic Press, London 1983
   Google Scholar
• Connors T. A. The Cancer Pharmacology Annual 2, B. A. Chabner, H. M. Pinedo. Elsevier/North-Holland, Amsterdam 1984
   Google Scholar
• Coune A., Sculieh J. P., Frühling J., Stryckmans P., Brassinne C., Ruysschaert J. M., Hildebrand J. I.v. administration of a water-insoluble antimitotic compound entrapped in liposomes. Preliminary report on infusion of large volumes of liposomes to man. Cancer Treatment Reports 1983; 67: 1031–1033
   PubMedGoogle Scholar
• Ellens H., Rustum Y., Mayhew E., Ledesma E. Distribution and metabolism of liposome-encapsulated and free 1-β — D-arabinofuranosylcytosin. Journal of Pharmacology and Experimental Therapeutics 1982; 222: 324–330
   PubMedGoogle Scholar
• Fichtner I., Arndt D., Elbe B., Reszka R. Cardiotoxicity of free and liposomally encapsulated rubomycin (daunorubicin) in mice. Oncology 1984; 41: 363–369
   PubMedGoogle Scholar
• Freise J., Müller W. H., Magerstedt P., Schmoll H. J. Pharmacokinetics of liposome encapsulated cisplatin in rats. Archives Internationales de Pharmacodynamic et de therapie 1982; 258: 180–192
   PubMedGoogle Scholar
• Liposome Technology, G. Gregoriadis. CRC Press, Boca Raton 1984
   Google Scholar
• Liposomes in Biological Systems, G. Gregoriadis, A. C. Allison. Wiley, Chichester 1980
   Google Scholar
• Großmann A., Reszka R., Arndt D. Quantitative Bestimmung alkylierender Substanzen in Liposomen. Pharmazie 1984; 39: 719
   Google Scholar
• Gutsche W., Jungstand W., Wohlrabe K. Vergleich der Wirkung von IMET 3393 mit Chlorambucil an einer Reihe von Transplantationstumoren. Zentralblatt für Pharmazie 1971; 110: 1033–1043
   Google Scholar
• Inaba M., Yoshida N., Tsukagoshi S. Preferential action of liposome entrapped 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea on lung metastases of Lewis lung carcinoma as compared with the free drug. Gann 1981; 72: 341–345
   PubMedGoogle Scholar
• Drug Delivery Systems, R. L. Juliano. Oxford University Press, Oxford 1980
   Google Scholar
• Khato J., Priester E. R., Sieber S. M. Enhanced lymph node uptake of melphalan following liposomal entrapment and effects on lymph node metastasis in rats. Cancer Treatment Reports 1982; 66: 517–527
   PubMedGoogle Scholar
• Kirby C., Gregoriadis G. The effect of lipid composition of small unilamellar liposomes containing Melphalan and Vincristin on drug clearance after injection into mice. Biochemical Pharmacology 1983; 32: 609–619
   PubMed Web of Science ®Google Scholar
• Laduron C., Atassi G., Hildebrand J., Ruysschaert J. M., Coune A., Stryckmans P., Brassinne C. Chemotherapeutic efficacy of NocodazoleR encapsulated in liposomes on L 1210 murine leukemia. Research Communications in Chemical Pathology and Pharmacology 1983; 39: 419–436
   PubMedGoogle Scholar
• Large P., Gregoriadis G. Phospholipid composition of small unilamellar liposomes containing Melphalan influences drug action in mice bearing PC 6 tumors. Biochemical Pharmacology 1983; 32: 1315–1317
   PubMedGoogle Scholar
• Maral R., Bourut C., Chenu C., Mathe G., Bernon R., Lussan C., Imbach J. L., Schein P., Bothorel P. Comparison of the experimental antitumor activities of three nitrosourea derivatives Chlorozoticin, RFCNU and CNCC encapsulated in liposomes with those in the free state. Oncology 1985; 4: 122–128
   Google Scholar
• Mathe G., Bothorel P. In vivo enhancement of the experimental oncostatic effect of RFCNU by its encapsulation in liposomes. Biomedicine 1981; 35: 201–202
   PubMedGoogle Scholar
• Nuhn P., Schenk P., Richter H., Arndt D., Jandrig J., Winsel K. Untersuchungen an Liposomen aus hydriertem Eilecithin. Pharmazie 1985; 40: 705–709
   PubMedGoogle Scholar
• Papahadjopoulos D. Liposomes and their use in biology and medicine. Annals of New York Academy of Sciences 1978; 308: 1–462
   PubMedGoogle Scholar
• Papahadjopoulos D., Poste G., Vail W. J., Biedler J. L. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells. Cancer Research 1976; 36: 2988–2995
   PubMed Web of Science ®Google Scholar
• Patel K. R., Jonah M. M., Rahman Y. E. In vitro uptake and therapeutic application of liposome-encapsulated methotrexate in mouse hepatoma 129. European Journal of Cancer and Clinical Oncology 1982; 18: 833–843
   PubMedGoogle Scholar
• Rahman A., White G., More N., Schein P. S. Pharmacological, toxicological, and therapeutic evaluation in mice of Doxorubicin entrapped in cardiolipin liposomes. Cancer Research 1985; 45: 769–803
   Web of Science ®Google Scholar
• Ritter C., Rutman R. J. Relative enhancement by various liposomes of BCNU effectiveness against L 1210 leukemia in vivo. Research Communications in Chemical Pathology and Pharmacology 1980; 30: 123–131
   PubMedGoogle Scholar
• Ryman B. E., Tyrrell D. A. Liposomes-Bags of Potential. Essays in Biochemistry 1980; 16: 49–98
   PubMedGoogle Scholar
• Schseier H., Raeder-Schikorr M. Liposomen-ein neuartiger Arzneistofftrager. Pharmazie in unserer Zeit 1982; 11: 97–108
   PubMedGoogle Scholar
• Singleton W. S., Grey M. S., Broen H. L. Chromatographically homogeneous lecithin from egg phospholipids. Journal of the American Oil Chemical Society 1965; 42: 53–56
   PubMed Web of Science ®Google Scholar
• Liposomes and Immunobiology, B. H. Tom, N. R. Six. Elsevier/North-Holland, Amsterdam 1980
   Google Scholar
• Weinstein J. N., Leserman L. D. Liposomes as drug carriers in cancer chemotherapy. Pharmacy and Therapy 1984; 24: 207–233
   PubMed Web of Science ®Google Scholar